Takeda Wins Bid For Stay In Actos Patent Battle

Law360, New York (October 9, 2007, 12:00 AM EDT) -- A federal judge has granted a bid by Takeda Pharmaceuticals Co. Ltd. to stay one lawsuit against Sandoz Inc. in a series of parallel proceedings the company has filed in its battle to bar generic firms from manufacturing copycat versions of its blockbuster diabetes treatment Actos.

In an opinion and order filed Tuesday in the U.S. District Court for the Southern District of New York, Judge Denise Cote granted Takeda’s July 27 cross-motion to stay the proceedings and denied two bids by Sandoz for judgment on...
To view the full article, register now.